Bijan Eghtesad, John J. Fung, Anthony J. Demetris, Noriko Murase, Roberta Ness, Debra C. Bass, Edward A. Gray, Obaid Shakil, Bridget Flynn, Amadeo Marcos, Thomas E. Starzl – 19 October 2005 – We retrospectively analyzed 42 hepatitis C virus (HCV)‐infected patients who underwent cadaveric liver transplantation under two strategies of immunosuppression: (1) daily tacrolimus (TAC) throughout and an initial cycle of high‐dose prednisone (PRED) with subsequent gradual steroid weaning, or (2) intraoperative antithymocyte globulin (ATG) and daily TAC that was later space weaned.

Hatem Khalaf, Hamad Al‐Suhaibani, Ali Al‐Mehaidib, Souheil Shabib, Jalal Bhuiyan, Mohamed S. Khuroo, Mohamed Al‐Sebayel – 19 October 2005

Peter Neuhaus – 19 October 2005

Heung Bae Kim, James J. Pomposelli, Craig W. Lillehei, Roger L. Jenkins, Maureen M. Jonas, Laura E. Krawczuk, Steven J. Fishman – 19 October 2005 – Extrahepatic portal vein thrombosis (EHPVT) may occur in children or adults and usually comes to clinical attention due to complications of portal hypertension such as variceal hemorrhage. A variety of standard surgical techniques exist to manage these patients, but when these fail surgical options are limited. We describe two novel portosystemic shunts that utilize the gonadal vein as an autologous conduit.

Maud Bessems, Benedict M. Doorschodt, Jan van Marle, Heleen Vreeling, Alfred J. Meijer, Thomas M. van Gulik – 19 October 2005 – Waiting lists for transplantation have stimulated interest in the use of non‐heart‐beating donor (NHBD) organs. Recent studies on organ preservation have shown advantages of machine perfusion (MP) over cold storage (CS). To supply the liver with specific nutrients during MP, the preservation solution Polysol was developed. The aim of our study was to compare CS in University of Wisconsin solution (UW) with MP using UW‐gluconate (UW‐G) or Polysol in an NHBD model.

Koichi Tanaka, John Lake, Federico Villamil, Gary Levy, Paul Marotta, Sergio Mies, Bernard de Hemptinne, Christian Moench – 19 October 2005 – New immunosuppressive agents and regimens should be evaluated specifically in living donor liver transplant patients due to potential clinical and pharmacokinetic differences between deceased donor and living donor transplant recipients.

Wagner C. Marujo, Flavio Takaoka, Rita M. A. Moura, Fernando L. Pandullo, Andre R. Morrone, Marcelo M. Linhares, Alexandre Teruya, Isaac Altikes – 19 October 2005 – Hydrothorax is a frequent finding in patients with end‐stage liver disease. During the hepatectomy phase of liver transplantation, it is often needed to evacuate large pleural effusions. The acute expansion of the collapsed lung can cause reexpansion pulmonary edema with variable clinical significance. However, this complication has rarely been reported after liver transplantation.

Andrew Cameron, Ronald W. Busuttil – 19 October 2005

Santiago J. Muñoz, Hisham ElGenaidi – 19 October 2005

Paul J. Thuluvath – 19 October 2005